哈佛大学的研究员Joan Brugge希望通过早期针对突变细胞来预防乳腺癌, 但由于与此无关的争议, 美国国家卫生研究院 (NIH) 资金被失, 威胁到她的实验室和美国的研究. Harvard researcher Joan Brugge aims to prevent breast cancer by targeting mutated cells early, but lost NIH funding over unrelated disputes, threatening her lab and U.S. research.

哈佛癌症研究家琼·布鲁格(Joan Brugge)说,她的团队的研究旨在预防乳腺癌,方法是在有基因突变的细胞致癌之前针对这些细胞,从而在这种疾病发作之前就予以抑制。 Harvard cancer researcher Joan Brugge said her team’s research aims to prevent breast cancer by targeting cells with genetic mutations before they become cancerous, potentially stopping the disease before it develops. 她在谈到“60分钟”时强调,早期干预的目标是为后代留出时间,尽管没有披露具体的方法、时间表或临床阶段。 Speaking on "60 Minutes," she emphasized the goal of early intervention to spare future generations, though specific methods, timelines, or clinical stages were not disclosed. 作为将癌症护理从治疗转向预防的更广泛努力的一部分,她的工作面临挑战,因为两笔NIH赠款因无关的政策争端而终止,引起人们对供资和学术自由的关切。 Her work, part of broader efforts to shift cancer care from treatment to prevention, faces challenges as two NIH grants were terminated over unrelated policy disputes, prompting concerns about funding and academic freedom. Brugge称取消活动是对她的实验室的一种生存威胁,并警告美国科学研究将面临更广泛的风险。 Brugge called the cancellations an existential threat to her lab and warned of broader risks to U.S. scientific research.